This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Depression, Postpartum
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The proposed study aims to establish the feasibility of light therapy for postpartum depression delivered via Re-Timer, demonstrate its preliminary efficacy, and illuminate relationships between circadian shifts and mood changes using a novel, home-based circadian biomarker assessment paradigm (salivary dim light melatonin onset; DLMO).

Provided treatments

  • Device: Light therapy
Tris trial is registered with FDA with number: NCT02769858. The sponsor of the trial is University of Michigan and it is looking for 10 volunteers for the current phase.
Official trial title:
The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression